Skip to main content
Search
News, Views, and Advocacy From the Oncology Nursing Society
ONS Voice Home
  • News & Views
  • Advocacy
  • Stories
  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • RSS
    • News & Views
    • Latest Articles
    • Clinical Practice
    • ONS News
    • ONS Leadership
    Trending Topics
    • Research
    • Treatments
    • Safety
    • COVID-19
    • Drug Reference Sheet
    • Special Populations
    View All Topics
    Advocacy
    • Latest Articles
    • Updates
    • Get Involved
    Stories View All
    View All
    Clinical and Pharmaceutical Nurse Educators Collaborate to Bring Training to Nurses and Improve Patient Care
    Oncology nurse education
    Clinical and Pharmaceutical Nurse Educators Collaborate to Bring Training to Nurses and Improve Patient Care
    January 13, 2023
    Oncology Nurse Uses Retirement to Help Patients and Healthcare Professionals Understand Pancreatic Cancer Biomarker Testing Results
    Pancreatic cancer
    Oncology Nurse Uses Retirement to Help Patients and Healthcare Professionals Understand Pancreatic Cancer Biomarker Testing Results
    November 11, 2022
    The Life of Marie Curie and Her Contributions to Oncology
    Cancer treatments
    The Life of Marie Curie and Her Contributions to Oncology
    November 07, 2022
    Post-Flooding Natural Disaster Cancer Considerations and Patient Education Points
    Patient safety
    Post-Flooding Natural Disaster Cancer Considerations and Patient Education Points
    September 28, 2022
    Can Patients Use Continuous Glucose Monitors During Radiation Therapy for Cancer?
    Radiation therapy
    Can Patients Use Continuous Glucose Monitors During Radiation Therapy for Cancer?
    August 19, 2022
    previous slide
    next slide
    Search
  • News & Views
  • Advocacy
  • Stories
    • Home

    Author Content

    Pancreatic Cancer Surveillance Programs Lead to Earlier Diagnoses and Better Outcomes
    Pancreatic cancer

    Pancreatic Cancer Surveillance Programs Lead to Earlier Diagnoses and Better Outcomes

    Most patients at high risk for developing pancreatic cancer whose disease was found while participating in a screening program were diagnosed with early-stage cancers, according to study findings published in the Journal of Clinical Oncology.

    January 25, 2023
    Aspirin’s Survival Benefits in Advanced CRC Depend on Patient BMI
    Cancer research

    Aspirin’s Survival Benefits in Advanced CRC Depend on Patient BMI

    Regular use of aspirin after an advanced colorectal cancer diagnosis may extend survival by as much as 14 months for patients with a healthy body mass index score prediagnosis compared to those with obese BMIs, researchers reported in JAMA Network Open.

    January 18, 2023
    Text-Messaging Prescreening Streamlines Treatment Visits and Care for ICI Toxicities
    Adverse events

    Text-Messaging Prescreening Streamlines Treatment Visits and Care for ICI Toxicities

    Prescreening patients for immune-related adverse events during treatment with immune checkpoint inhibitors using text messaging may reduce the need for some in-person, preinfusion office visits, researchers reported in JAMA Network Open. The approach may help decrease the burden of cancer care for both patients and providers.

    January 11, 2023
    Achieve Equity in Patient Communication With These Evidence-Based Approaches
    Special Populations

    Achieve Equity in Patient Communication With These Evidence-Based Approaches

    Equalizing the quality of patient-provider communication for Black versus White patients is one way to reduce the systemic racial disparities prevalent in cancer care, researchers reported in study findings published in the November 2022 issue of the Oncology Nursing Forum. They identified critical opportunities for oncology nurses to improve interpersonal communication with Black patients. Nurses are key drivers to affecting change and cancer outcomes for all patients, they reported.

    January 10, 2023
    Hispanic Patients Are at Higher Risk for Aggressive Prostate Cancer but Less Likely to Get Treatment
    Special Populations

    Hispanic Patients Are at Higher Risk for Aggressive Prostate Cancer but Less Likely to Get Treatment

    Compared to their non-Hispanic White counterparts, most Hispanic patients with localized prostate cancer are nearly 20% more likely to have aggressive disease, but the risk varies based on their country of origin, researchers reported in study findings published in Prostate Cancer and Prostatic Diseases. Additionally, they found that the population faces disparities in access to care, with only approximately 60% receiving appropriate treatment.

    January 05, 2023
    During or After Chemo, Exercise Fights Fatigue and Supports Cancer Recovery
    Chemotherapy

    During or After Chemo, Exercise Fights Fatigue and Supports Cancer Recovery

    Patients who engage in physical activity during or after cancer treatment are less fatigued and return to their usual daily activities faster than those who don’t exercise, researchers reported in JACC: CardioOncology. The benefit is highest among patients who are active during treatment but still pronounced for those who resume physical activity after completing treatment.

    January 04, 2023
    Rural Patients Who Miss Radiation Doses Are More Likely to Die From Cancer
    Radiation therapy

    Rural Patients Who Miss Radiation Doses Are More Likely to Die From Cancer

    Regardless of residence, nearly 25% of patients with cancer overall miss at least 10% of the doses in their radiation treatment plans—but the implications on outcomes are far greater for patients living in rural areas than their urban counterparts, according to new research findings published in the International Journal of Radiation Oncology, Biology, Physics.

    December 28, 2022
    Chemo Combo May Be a Bladder Cancer Treatment Alternative During BCG Shortage
    Chemotherapy

    Chemo Combo May Be a Bladder Cancer Treatment Alternative During BCG Shortage

    Overall survival among patients with non–muscle-invasive bladder cancer who are treated with adjuvant gemcitabine and docetaxel is comparable to overall survival for treatment with bacillus Calmette-Guérin (BCG), researchers reported in the Journal of Urology. The evidence could support a treatment alternative for high-risk patients during the BCG shortage.

    December 21, 2022
    New Cancer Drugs Launch at Record-High Prices
    Prescription medication

    New Cancer Drugs Launch at Record-High Prices

    Inflating more than 50% since 2017, the annual price of newly launched cancer drugs averages $283,000 in 2022, according to a new report from the office of U.S. Representative Katie Porter (D-CA). Although new drugs for any condition are also seeing record-breaking high prices, the cost of new anticancer therapeutics is 3.7 times higher than that of non-oncology drugs.

    December 14, 2022
    Even During Routine Cancer Care, Financial Hardship Significantly Increases Mortality
    Patient financial advocacy

    Even During Routine Cancer Care, Financial Hardship Significantly Increases Mortality

    Patients with cancer experiencing financial hardship during routine care are nearly 1.5 times more likely to die than those who aren’t, researchers reported in study findings published in JCO Oncology Practice.

    December 13, 2022
    Oncology Nurse Navigator Roles Are Transforming Cancer Outcomes for Underserved Rural Patients
    Nurse navigator

    Oncology Nurse Navigator Roles Are Transforming Cancer Outcomes for Underserved Rural Patients

    Underserved, rural, and economically disadvantaged patients with cancer who are under the care of an oncology nurse navigator are better prepared to begin treatment and require fewer services than non-navigated peers, according to study findings published in the Oncology Nursing Forum (ONF). Authors Williams et al. said that their results indicate greater patient satisfaction.

    December 08, 2022
    Engaging Community Health Workers Reduces Hospitalizations, Increases Psychosocial, Palliative, and EOL Care
    End of life (EOL)

    Engaging Community Health Workers Reduces Hospitalizations, Increases Psychosocial, Palliative, and EOL Care

    Patients with advanced cancer who met with community health workers between their regular cancer care appointments were less likely to require acute care and more likely to participate in advance care planning and receive mental health, palliative, and hospice care, according to study findings published in JAMA Oncology.

    December 07, 2022
    Healthy Lifestyles Reduce Prostate Cancer Mortality in Patients With Genetic Risk
    Prostate cancer

    Healthy Lifestyles Reduce Prostate Cancer Mortality in Patients With Genetic Risk

    Patients with germline genetic variants that increase their risk of developing prostate cancer have a lower risk of developing lethal disease when following a healthy lifestyle, according to study findings that researchers reported in European Urology.

    November 23, 2022
    Micro-Organospheres Create Molecular Model of Patients’ Cancer in Just Two Weeks
    Cancer treatments

    Micro-Organospheres Create Molecular Model of Patients’ Cancer in Just Two Weeks

    Biomarker- and molecular-driven technologies such as molecular models can precisely predict how an individual’s cancer will respond to certain treatments, the pinnacle of precision oncology. However, established modeling systems such as patient-derived xenografts and patient-derived organoids require large tissue samples and take months or even a year to obtain results, barriers that have limited their application in regular practice.

    November 16, 2022
    Biomarkers Are Associated With Frailty After Chemo for Breast Cancer
    Breast cancer

    Biomarkers Are Associated With Frailty After Chemo for Breast Cancer

    High levels of interleukin-6 (IL-6) and C-reactive protein before chemotherapy for breast cancer may predict a patient’s propensity to develop clinical decline and frailty after treatment, according to study findings that researchers reported in the Journal of Clinical Oncology.

    November 09, 2022
    Cortisol Biomarkers Help Researchers Understand Chemotherapy-Induced Peripheral Neuropathy
    Chemotherapy

    Cortisol Biomarkers Help Researchers Understand Chemotherapy-Induced Peripheral Neuropathy

    Clinicians and researchers know little about the mechanisms for chemotherapy-induced peripheral neuropathy, a side effect of neurotoxic agents that can cause numbness, tingling, and pain in the upper and lower extremities. Until recently, mechanism-based treatment was difficult, but biomarkers are helping nurse scientists identify a potential connection to the hypothalamic-pituitary-adrenal axis.

    November 03, 2022
    Most Lung Cancer Genetic Variants Are Clinically Actionable and All Patients Should Get Biomarker Testing
    Cancer research

    Most Lung Cancer Genetic Variants Are Clinically Actionable and All Patients Should Get Biomarker Testing

    More than 95% of germline genetic variants identified through genetic testing in patients with lung cancer are potentially clinically actionable, researchers reported in study findings during the 2022 ASCO Plenary Series Program, leading them to recommend testing all patients with the disease.

    November 02, 2022
    Androgen Receptor Signaling May Contribute to Melanoma Treatment Resistance
    Melanoma

    Androgen Receptor Signaling May Contribute to Melanoma Treatment Resistance

    Poorer outcomes among males receiving BRAF or MEK inhibitors for melanoma may be related to an increase in androgen receptors, researchers discovered in study findings published in Nature.

    October 26, 2022
    Nurse-Led Online Intervention Improves Symptoms, Control, and QOL in Ovarian Cancer
    Ovarian cancer

    Nurse-Led Online Intervention Improves Symptoms, Control, and QOL in Ovarian Cancer

    An eight-week online symptom self-management program, which can be facilitated by a nurse, significantly improves symptom burden, sense of control, and quality of life among patients with ovarian cancer. Researchers reported the evidence in the Journal of Clinical Oncology.

    October 19, 2022
    Caregiving for Metastatic Prostate Cancer Is Nearly a Full-Time Job
    Caregiver strain

    Caregiving for Metastatic Prostate Cancer Is Nearly a Full-Time Job

    Caregivers spend an average of 30 hours per week caring for patients with metastatic prostate cancer, researchers reported in study findings published in the Journal of Clinical Oncology.

    October 12, 2022
    Precision Oncology Models Guide Tailored Nursing Interventions for Ovarian Cancer Symptom Clusters
    Ovarian cancer

    Precision Oncology Models Guide Tailored Nursing Interventions for Ovarian Cancer Symptom Clusters

    Using the National Institutes of Health Symptom Science Model and Nursing Science Precision Health Model helps oncology nurses to recognize symptoms more promptly in patients with ovarian cancer and provide precision interventions that address racial disparities and foster equity in symptom-focused, patient-centered care, Mahoney and Pierce reported in the October 2022 issue of the Clinical Journal of Oncology Nursing.

    October 11, 2022
    Tumor-Infiltrating Lymphocytes Activate Immune Response to Metastatic Breast Cancer
    Breast cancer

    Tumor-Infiltrating Lymphocytes Activate Immune Response to Metastatic Breast Cancer

    More than two-thirds of patients with hormone receptor–positive metastatic breast cancer respond to personalized immunotherapy with tumor-infiltrating lymphocytes and more than half of those treated experience measurable tumor shrinkage, according to study findings published in the Journal of Clinical Oncology.

    October 05, 2022
    Hispanic Patients See Highest Increase Among Uterine Cancer’s Growing Mortality Rate
    Cancer health disparities

    Hispanic Patients See Highest Increase Among Uterine Cancer’s Growing Mortality Rate

    Racial and ethnic groups are disproportionately affected by the increase in uterine cancer mortality in the United States, researchers explained in study findings published in JAMA Oncology, with Hispanic patients experiencing the highest burden.

    September 28, 2022
    Testicular Cancer Survivors May Need Fewer Monitoring Scans
    Cancer screening

    Testicular Cancer Survivors May Need Fewer Monitoring Scans

    Monitoring early-stage testicular cancer survivors for disease recurrence after surgery using either magnetic resonance imaging or fewer computed tomography scans is just as effective as more frequent intervals, researchers reported in study findings published in the Journal of Clinical Oncology.

    September 21, 2022
    Certain Cancers May Increase Risk of Type 2 Diabetes
    Research

    Certain Cancers May Increase Risk of Type 2 Diabetes

    Patients with lung, pancreatic, breast, brain, urinary tract, or uterine cancers may be more likely to develop new-onset type 2 diabetes after their cancer diagnosis, according to research findings published in Diabetes Care, and those who went on to develop type 2 diabetes experienced poorer overall health outcomes.

    September 14, 2022
    • Current page 1
    • Page 2
    • Page 3
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9
    • …
    • Next page
    • Last page Last »

    To discuss the information in this article with other oncology nurses, visit the ONS Communities.

    To report a content error, inaccuracy, or typo, email pubONSVoice@ons.org.

    content['#byline_profile'].image_alt_text
    Elisa Becze BA, ELS, Editor
     
    Home
    News, Views, and Advocacy From the Oncology Nursing Society
  • Legal Notices
  • Contact Us
  • Conferences
  • Advertising
  • Newsroom
  • Sitemap

  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • RSS
  • ONS
  • Oncology Nursing Foundation
  • ONCC
    • © Copyright 2023 Oncology Nursing Society
     
    Back to Top ▲